Cost-Effectiveness of Primary Radiation Therapy Versus Radical Prostatectomy for Intermediate- to High-Risk Prostate Cancer

Journal Article · Thu Feb 15 04:00:00 EST 2018 · International Journal of Radiation Oncology, Biology and Physics

DOI:https://doi.org/10.1016/J.IJROBP.2017.10.024· OSTI ID:23082832

Lee, W. Robert; Chino, Junzo ^[1]; Abouassaly, Robert ^[2]; Ellis, Rodney J. ^[3]; Myers, Evan R. ^[4]

---

1. Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina (United States)
2. Department of Urology, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland (United States)
3. Department of Radiation Oncology, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland (United States)
4. Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina (United States)

To compare, using a cost-effectiveness analysis, the quality-adjusted life expectancy (QALE) and cost between the 2 treatment options for intermediate- to high-risk prostate cancer: (1) radiation (RT) with androgen deprivation therapy (ADT) or (2) radical prostatectomy (RP) followed by adjuvant RT for patients with risk factors.

• OSTI ID: 23082832
• Journal Information: International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 2 Vol. 100; ISSN IOBPD3; ISSN 0360-3016
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
ANDROGENS
COST EFFECTIVENESS ANALYSIS
NEOPLASMS
PATIENTS
PROSTATE
RADIOTHERAPY